Bupropion and dextromethorphan for reduction of suicide risk in depression patients | Patent Publication Number 20230293456
US 20230293456 A1Patent NumberUS 11896563 B2
Application Number18323714
Filled DateMay 25, 2023
Priority DateDec 1, 2020
Publication DateSep 21, 2023
Original AssigneeAxsome Therapeutics Inc.
Current AssigneeAntecip Bioventures Ii Llc Axsome
Inventor/ApplicantsHerriot Tabuteau
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.